APA引文

ITO, Y., ONODA, N., KUDO, T., MASUOKA, H., HIGASHIYAMA, T., KIHARA, M., . . . MIYAUCHI, A. (2021). Sorafenib and Lenvatinib Treatment for Metastasis/Recurrence of Radioactive Iodine-refractory Differentiated Thyroid Carcinoma. In Vivo.

Citação norma Chicago

ITO, YASUHIRO, NAOYOSHI ONODA, TAKUMI KUDO, HIROO MASUOKA, TAKUYA HIGASHIYAMA, MINORU KIHARA, AKIHIRO MIYA, and AKIRA MIYAUCHI. "Sorafenib and Lenvatinib Treatment for Metastasis/Recurrence of Radioactive Iodine-refractory Differentiated Thyroid Carcinoma." In Vivo 2021.

MLA引文

ITO, YASUHIRO, et al. "Sorafenib and Lenvatinib Treatment for Metastasis/Recurrence of Radioactive Iodine-refractory Differentiated Thyroid Carcinoma." In Vivo 2021.